Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
RECURSION PHARMACEUTICALS, INC. market cap for the quarter ending 2026-07-31 was $1.61B, a 26.52% decline year-over-year.
RECURSION PHARMACEUTICALS, INC. market cap for the quarter ending 2026-06-30 was $1.96B, a 10.20% decline year-over-year.
RECURSION PHARMACEUTICALS, INC. market cap for the quarter ending 2026-03-31 was $1.63B, a 24.23% decline year-over-year.
RECURSION PHARMACEUTICALS, INC. market cap for the quarter ending 2025-12-31 was $2.16B, a 19.56% decline year-over-year.
RECURSION PHARMACEUTICALS, INC. market cap for fiscal 2026 was $1.61B.
RECURSION PHARMACEUTICALS, INC. market cap for fiscal 2025 was $2.16B, a 19.56% decline from fiscal 2024.
RECURSION PHARMACEUTICALS, INC. market cap for fiscal 2024 was $2.68B, a 16.13% increase from fiscal 2023.
RECURSION PHARMACEUTICALS, INC. market cap for fiscal 2023 was $2.31B, a 56.84% increase from fiscal 2022.